REVIVE THERAPEUTICS LTD COM's ticker is RVVTF and the CUSIP is 761516103. A total of 5 filers reported holding REVIVE THERAPEUTICS LTD COM in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11 | -99.9% | 130,000 | +18.7% | 0.00% | -100.0% |
| Q3 2022 | $19,000 | -45.7% | 109,500 | +10.1% | 0.00% | 0.0% |
| Q2 2022 | $35,000 | +150.0% | 99,500 | -0.5% | 0.00% | – |
| Q1 2022 | $14,000 | -65.0% | 100,000 | -33.3% | 0.00% | -100.0% |
| Q4 2021 | $40,000 | -24.5% | 150,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $53,000 | -25.4% | 150,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $71,000 | +24.6% | 150,000 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $57,000 | +16.3% | 150,000 | +50.0% | 0.00% | 0.0% |
| Q4 2020 | $49,000 | +172.2% | 100,000 | +8.7% | 0.00% | 0.0% |
| Q3 2020 | $18,000 | -10.0% | 92,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $20,000 | – | 92,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 5,000 | $1,000 | 0.00% |
| GOFEN & GLOSSBERG LLC /IL/ | 100,000 | $14,000 | 0.00% |
| American Research & Management Co. | 1,000 | $0 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 15,500 | $2,000 | 0.00% |